Title : Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma.

Pub. Date : 2013 Jan

PMID : 23266925






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We report the outcome of the first patient treated in a phase 1 study for relapsed neuroblastoma, using the chemotherapy agent decitabine to upregulate cancer testis antigen expression, followed by a dendritic cell vaccine targeting the cancer testis antigens MAGE-A1, MAGE-A3, and NY-ESO-1. Decitabine MAGE family member A3 Homo sapiens